Psychedelics and Depression
Psilocybin shows promise in treating major depression, often providing relief through immersive experiences in controlled settings. While microdosing is discussed, it appears less impactful compared to higher doses administered during clinical sessions. The underlying mechanisms involve neuroplasticity and a complex interplay of neurotransmitters, suggesting that individual responses to psychedelics may vary significantly.In this clip
From this podcast
Huberman Lab
Understanding & Conquering Depression | Huberman Lab Podcast #34
Related Questions
How effective is psilocybin for treating depression according to the episode Leading Integrative Psychiatrist | The Truth About Ketamine, MDMA and Psilocybin Assisted Therapy and the clip Psilocybin and Healing?
How does psilocybin compare to ketamine for treating depression based on the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Ketamine and Psychedelics?
What does the research say about psilocybin microdosing as discussed in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Microdosing Insights?